NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019Deborah K. Armstrong, Anita M. Engh, Jamie N. Bakkum‐Gamez et al.|Journal of the National Comprehensive Cancer Network|2019Cited by 332
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket StudyYoshiaki Nakamura, Tanios Bekaii‐Saab, Nobumasa Mizuno et al.|Journal of Clinical Oncology|2023Cited by 100
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET StudyAna Oaknin, Anna V. Tinker, Bhavana Pothuri et al.|Clinical Cancer Research|2023Cited by 80
Origin and frequency of 2n gametes in Citrus sinensis×Poncirus trifoliata and their reciprocal crossesChunxian Chen, Frederick G. Gmitter, Matthew T. Lyon et al.|Plant Science|2007Cited by 54
“More than a song and dance”: Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTokMolly Morton, Laura Chambers, Paulina Haight et al.|Gynecologic Oncology|2023Cited by 15